JP2017537702A - 前駆細胞を用いた眼球症状の治療法 - Google Patents

前駆細胞を用いた眼球症状の治療法 Download PDF

Info

Publication number
JP2017537702A
JP2017537702A JP2017529751A JP2017529751A JP2017537702A JP 2017537702 A JP2017537702 A JP 2017537702A JP 2017529751 A JP2017529751 A JP 2017529751A JP 2017529751 A JP2017529751 A JP 2017529751A JP 2017537702 A JP2017537702 A JP 2017537702A
Authority
JP
Japan
Prior art keywords
cells
cell
tsp
derived
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017529751A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017537702A5 (cg-RX-API-DMAC10.html
Inventor
ハリス，イアン
ソフィア デイネカ，ナディン
ソフィア デイネカ，ナディン
Original Assignee
ヤンセン バイオテツク，インコーポレーテツド
ヤンセン バイオテツク，インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヤンセン バイオテツク，インコーポレーテツド, ヤンセン バイオテツク，インコーポレーテツド filed Critical ヤンセン バイオテツク，インコーポレーテツド
Publication of JP2017537702A publication Critical patent/JP2017537702A/ja
Publication of JP2017537702A5 publication Critical patent/JP2017537702A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/062—Sensory transducers, e.g. photoreceptors; Sensory neurons, e.g. for hearing, taste, smell, pH, touch, temperature, pain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
    • C12N2502/025—Coculture with; Conditioned medium produced by embryonic cells extra-embryonic cells, e.g. amniotic epithelium, placental cells, Wharton's jelly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2017529751A 2014-12-05 2015-12-04 前駆細胞を用いた眼球症状の治療法 Pending JP2017537702A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462088429P 2014-12-05 2014-12-05
US62/088,429 2014-12-05
US201562126370P 2015-02-27 2015-02-27
US62/126,370 2015-02-27
US201562220873P 2015-09-18 2015-09-18
US62/220,873 2015-09-18
PCT/US2015/063923 WO2016090215A2 (en) 2014-12-05 2015-12-04 Treatment of ocular conditions using progenitor cells

Publications (2)

Publication Number Publication Date
JP2017537702A true JP2017537702A (ja) 2017-12-21
JP2017537702A5 JP2017537702A5 (cg-RX-API-DMAC10.html) 2019-03-22

Family

ID=56092673

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017529751A Pending JP2017537702A (ja) 2014-12-05 2015-12-04 前駆細胞を用いた眼球症状の治療法

Country Status (16)

Country Link
US (1) US20160158293A1 (cg-RX-API-DMAC10.html)
EP (1) EP3258946A4 (cg-RX-API-DMAC10.html)
JP (1) JP2017537702A (cg-RX-API-DMAC10.html)
KR (1) KR20170093178A (cg-RX-API-DMAC10.html)
CN (1) CN107206028A (cg-RX-API-DMAC10.html)
AU (1) AU2015358330A1 (cg-RX-API-DMAC10.html)
BR (1) BR112017011513A2 (cg-RX-API-DMAC10.html)
CA (1) CA2969690A1 (cg-RX-API-DMAC10.html)
HK (1) HK1250329A1 (cg-RX-API-DMAC10.html)
MX (1) MX2017007207A (cg-RX-API-DMAC10.html)
PH (1) PH12017500998A1 (cg-RX-API-DMAC10.html)
RU (1) RU2017123184A (cg-RX-API-DMAC10.html)
SG (1) SG11201704268TA (cg-RX-API-DMAC10.html)
TW (1) TW201636032A (cg-RX-API-DMAC10.html)
WO (1) WO2016090215A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA201704521B (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
WO2018102174A1 (en) * 2016-12-01 2018-06-07 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
GB201703058D0 (en) 2017-02-24 2017-04-12 Ucl Business Plc Biomarkers
JP7348892B2 (ja) * 2019-12-30 2023-09-21 佛教慈濟醫療財團法人 眼疾患を予防または治療する組成物及び方法
WO2021207282A2 (en) * 2020-04-07 2021-10-14 Combangio, Inc. Lyophilized mesenchymal stem cell derived secretome and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100272803A1 (en) * 2003-06-27 2010-10-28 Sanjay Mistry Repair and regeneration of ocular tissue using postpartum-derived cells
JP2014520843A (ja) * 2011-07-11 2014-08-25 チャバイオ＆ディオステック カンパニー，リミテッド 臍帯抽出物の製造方法及びその用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2569780T3 (es) * 2003-06-27 2016-05-12 DePuy Synthes Products, Inc. Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas
CA2761610C (en) * 2009-05-13 2020-12-29 Medipost Co., Ltd. Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof
US20130251670A1 (en) * 2011-09-13 2013-09-26 Aidan Products, Inc Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100272803A1 (en) * 2003-06-27 2010-10-28 Sanjay Mistry Repair and regeneration of ocular tissue using postpartum-derived cells
JP2014520843A (ja) * 2011-07-11 2014-08-25 チャバイオ＆ディオステック カンパニー，リミテッド 臍帯抽出物の製造方法及びその用途

Also Published As

Publication number Publication date
MX2017007207A (es) 2018-01-30
BR112017011513A2 (pt) 2018-07-10
RU2017123184A3 (cg-RX-API-DMAC10.html) 2019-07-17
CN107206028A (zh) 2017-09-26
US20160158293A1 (en) 2016-06-09
TW201636032A (zh) 2016-10-16
EP3258946A4 (en) 2018-08-01
PH12017500998A1 (en) 2017-12-18
SG11201704268TA (en) 2017-06-29
ZA201704521B (en) 2019-01-30
KR20170093178A (ko) 2017-08-14
WO2016090215A2 (en) 2016-06-09
RU2017123184A (ru) 2019-01-10
HK1250329A1 (zh) 2018-12-14
CA2969690A1 (en) 2016-06-09
AU2015358330A1 (en) 2017-06-08
EP3258946A2 (en) 2017-12-27

Similar Documents

Publication Publication Date Title
JP4950660B2 (ja) 分娩後由来細胞を使用する眼組織の修復および再生
JP5425400B2 (ja) 産褥由来細胞を用いた脳卒中および他の急性神経変性障害の治療
JP6000982B2 (ja) 臍由来細胞を使用する筋萎縮性側索硬化症の治療
JP2018500325A (ja) 前駆細胞を用いた網膜変性の治療法
TW201908478A (zh) 調節米勒神經膠質細胞之方法
US20160158293A1 (en) Treatment of Ocular Conditions Using Progenitor Cells
JP2019524688A (ja) 前駆細胞を用いた網膜血管疾患の治療
TW201836623A (zh) 使用前驅細胞治療視網膜變性
JP2019501888A (ja) 前駆細胞を用いた網膜変性の治療

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20181203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20191210

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200630